Advance Search | Bentham Science

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 927-939
Author(s): E. Giovannetti,M. Labots,H. Dekker,E. Galvani,J.S.W. Lind,R. Sciarrillo,R. Honeywell,E.F. Smit,H.M. Verheul,G.J. Peters

The PARAMOUNT Trial: A Phase III Randomized Study of Maintenance Pemetrexed Versus Placebo Immediately Following Induction First-line Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 1 Year: 2013 Page: 23-28
Author(s): Cesare Gridelli,Paolo Maione,Antonio Rossi

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 818-832
Author(s): Elena Galvani,Roberta Alfieri,Elisa Giovannetti,Andrea Cavazzoni,Silvia La Monica,Maricla Galetti,Claudia Fumarola,Mara Bonelli,Marco Mor,Marcello Tiseo,Godefridus J. Peters,Pier Giorgio Petronini,Andrea Ardizzoni

Irinotecan Resistance is Accompanied by Upregulation of EGFR and Src Signaling in Human Cancer Models

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 958-964
Author(s): Amelie Petitprez,Annette K. Larsen

Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities

Journal: Current Molecular Medicine
Volume: 13 Issue: 3 Year: 2013 Page: 358-367
Author(s): J.-J. Zhu,E. T. Wong

New Molecular Targets in the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5333-5343
Author(s): Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Francesca Casaluce, Assunta Sgambato, Cesare Gridelli

Genetics and Epigenetics of Lung Cancer: Mechanisms and Future Perspectives

Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 97-110
Author(s): Samriddhi Shukla,Sajid Khan,Trygve O. Tollefsbol,Syed M. Meeran

The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 907-917
Author(s): An Wouters,Carolien Boeckx,Jan B. Vermorken,Danielle Van den Weyngaert,Marc Peeters,Filip Lardon

Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 918-926
Author(s): L. Porcelli,A.E. Quatrale,P. Mantuano,N. Silvestris,J.F. Rolland,L. Biancolillo,A. Paradiso,A. Azzariti

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "erlotinib"